Anti-Hu CD80 PE-Cy1535

Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Dry Ice Shipment: No

Alternative Products

Cat	Name
MBS1801130-01	Anti-Hu CD80 PE
MBS1801130-02	Anti-Hu CD80 PE
MBS1801132-01	Anti-Hu CD80 PE-Cyanine7
MBS1801133-01	Anti-Hu CD80 PE-Cyanine5
MBS1801132-02	Anti-Hu CD80 PE-Cyanine7
MBS1801133-02	Anti-Hu CD80 PE-Cyanine5
MBS1801128-01	Anti-Hu CD80 APC
MBS1801131-01	Anti-Hu CD80 PerCP
MBS1801129-02	Anti-Hu CD80 FITC
MBS1801128-02	Anti-Hu CD80 APC

CAT:

270-T8-287-T025

Size:

25 Tests

Price:

Ask

For price, please contact [email protected].

Anti-Hu CD80 PE-Cy1535

Clone: MEM-233
Format: PE-Cy1535
Buffer: Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
References & Citations: *Kolar GR, Mehta D, Pelayo R, Capra JD: A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007 Mar 15109(6):2545-52., URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18521,*Lee DJ, Sieling PA, Ochoa MT, Krutzik SR, Guo B, Hernandez M, Rea TH, Cheng G, Colonna M, Modlin RL: LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007 Dec 15179(12):8128-36., URL: https://www.ncbi.nlm.nih.gov/pubmed/18056355,*Campioni D, Moretti S, Ferrari L, Punturieri M, Castoldi GL, Lanza F: Immunophenotypic heterogeneity of bone marrow-derived mesenchymal stromal cells from patients with hematologic disorders: correlation with bone marrow microenvironment. Haematologica. 2006 Mar91(3):364-8. , URL: https://www.ncbi.nlm.nih.gov/pubmed/16531259?dopt=,*Hovden AO, Karlsen M, Jonsson R, Aarstad HJ, Appel S: Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses. BMC Immunol. 2011 Jan 512:2., URL: http://www.ncbi.nlm.nih.gov/pubmed/21208424 ,*Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol Ther. 2005 May11(5):790-800., URL: http://www.ncbi.nlm.nih.gov/pubmed/15851017 ,*Derdak SV, Kueng HJ, Leb VM, Neunkirchner A, Schmetterer KG, Bielek E, Majdic O, Knapp W, Seed B, Pickl WF: Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules. Proc Natl Acad Sci U S A. 2006 Aug 29103(35):13144-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/16924110 ,*Silk KM, Leishman AJ, Nishimoto KP, Reddy A, Fairchild PJ: Rapamycin Conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype. J. Biomed. Biotechnol., vol. 2012, article ID 172420, 11 pages, doi:10.1155/2012/172420, URL: ,*Zhan H, Towler HM, Calder VL: The immunomodulatory role of human conjunctival epithelial cells. Invest Ophthalmol Vis Sci. 2003 Sep44(9):3906-10., URL: https://www.ncbi.nlm.nih.gov/pubmed/12939308,*Allen JS, Pang K, Skowera A, Ellis R, Rackham C, Lozanoska-Ochser B, Tree T, Leslie RD, Tremble JM, Dayan CM, Peakman M: Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture. Diabetes. 2009 Jan58(1):138-45., URL: https://pubmed.ncbi.nlm.nih.gov/18835928/,*Lee DJ, Sieling PA, Ochoa MT, Krutzik SR, Guo B, Hernandez M, Rea TH, Cheng G, Colonna M, Modlin RL: LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007 Dec 15179(12):8128-36., URL: https://pubmed.ncbi.nlm.nih.gov/18056355/,
Other References: *Vasilevko V, Ghochikyan A, Holterman MJ, Agadjanyan MG: CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA. DNA Cell Biol. 2002 Mar21(3):137-49., URL: https://www.ncbi.nlm.nih.gov/pubmed/12015893?ordin,*Yadav D, Judkowski V, Flodstrom-Tullberg M, Sterling L, Redmond WL, Sherman L, Sarvetnick N: B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J Immunol. 2004 Sep 15173(6):3631-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/15356107?ordin,*Vasilevko V, Ghochikyan A, Holterman MJ, Agadjanyan MG: CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA. DNA Cell Biol. 2002 Mar21(3):137-49., URL: https://www.ncbi.nlm.nih.gov/pubmed/12015893?ordin,

Complementary Product Range

Our range of products, including Anti-Hu CD80 PE-Cy1535, falls within the same field of application and can be used across various research projects. These products are carefully selected for their high performance and reliability, supporting the diverse needs of modern laboratories. Whether for ongoing studies or future experiments, they are designed to help researchers achieve their scientific goals. Here are some related products that may be of interest for similar or future applications:

Each item in our collection, is tested for precision and quality, ensuring dependable solutions for your research. As we continue to incorporate the latest advancements, Gentaur ensures that our product range remains relevant and versatile, providing you with the tools needed for both current and future projects.

Find us on

Cat	Name
T8-287-T025	Anti-Hu CD80 PE-Cy1535
T8-287-T100	Anti-Hu CD80 PE-Cy1535
T8-160-T100	Anti-Hu CD45 PE-Cy1535
T8-222-T100	Anti-Hu CD45 PE-Cy1535
T8-230-T025	Anti-Hu CD55 PE-Cy1535
T8-230-T100	Anti-Hu CD55 PE-Cy1535
T8-293-T025	Anti-Hu CD14 PE-Cy1535
T8-306-T025	Anti-Hu CD21 PE-Cy1535
T8-309-T100	Anti-Hu CD41 PE-Cy1535
T8-320-C025	Anti-Hu IgM PE-Cy1535